Natalie L. Kahn
Moderna Therapeutics, a Cambridge-based biotechnology company, is at the forefront of coronavirus vaccine development. The company recently received FDA approval to move onto Phase 2 of vaccine testing, in addition to $500 million in grants.
As schools around the country transition to virtual learning, LabXChange — a new scientific learning platform built by Harvard — allows STEM students the opportunity to mimic a science classroom and lab experience.
The Office for the Arts launched a digital series called "Pause for Art" featuring artistic performances by Harvard affiliates, with the aim of providing viewers a sense of community through music, poetry, and other art forms.
Former U.S. Secretary of Energy Ernest J. Moniz and former Deputy Secretary of Energy Daniel B. Poneman ’78 discussed the importance of nuclear energy in an event moderated by Harvard Kennedy School Professor Meghan L. O’Sullivan at the Institute of Politics Monday night.
Daniel L. Everett, a linguist, introduced his newest book and discussed the origins of language with a crowd of more than 200 Wednesday.
Theoretical physicist and Columbia University professor Brian R. Greene ’84 emphasized humanity’s unique place in the cosmos — despite occupying a miniscule sliver of space and time — at a Science Center talk Wednesday night.